This chart shows the drugs with the most patents in Ukraine. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Ukraine…
Which pharmaceutical drugs have the most drug patents in Ukraine? Read Post »
Annual Drug Patent Expirations for ZOLINZA Zolinza is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from one supplier. There are nine…
The post New patent expiration for Msd Sub drug ZOLINZA appeared first on DrugPatentWa…
Annual Drug Patent Expirations for NORMOCARB+HF+25 Normocarb Hf 25 is a drug marketed by Dialysis Sups and is included in one NDA. There is one patent protecting this drug. This…
The post New patent expiration for Dialysis Sups drug NORMOCARB HF 25 app…
New patent expiration for Dialysis Sups drug NORMOCARB HF 25 Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from two suppliers. There are eight patents…
The post New patent for Jazz Pharms drug XYREM appeared first on DrugPatentWatch -…
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have supplementary protec…
Which drugs have supplementary protection certificates in the most countries? Read Post »
ZOLINZA (vorinostat) Msd sub merck Patent: 8,067,472 Expiration: Mar 4, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Patent E…
Drug Patent Expirations for the Week of February 26, 2023 Read Post »
Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-five…
The post New patent for Teva Pharm drug ARMONAIR DIGIHALER a…
New patent for Teva Pharm drug ARMONAIR DIGIHALER Read Post »
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on DrugP…
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Teva Pharm drug ARMONAIR RESPICLICK a…
New patent for Teva Pharm drug ARMONAIR RESPICLICK Read Post »
Get new actionable insights and updates from BiotechBlog
